CareDx, Inc. (CDNA) Stock

About CareDx, Inc.

CareDx, Inc. is led by CEO John Walter Hanna Jr., employs 644 people, headquartered in US, publicly traded since 2014.

CareDx, Inc. (CDNA) stock trades at $69.21 with a market capitalization of $3.58B. The stock is valued at a price-to-earnings (P/E) ratio of 30.21, price-to-book of 7.86, price-to-sales of 7.34. Over the past 52 weeks the stock has ranged between $13.95 and $71.25, and currently trades 2.9% below its 52-week high.

On profitability, CareDx, Inc. generates a return on equity (ROE) of 32.81%, above the typical market range of roughly 12-15%, return on capital employed of -0.96%, an operating margin of -3.20%, a net profit margin of 24.23%.

CareDx, Inc. by the numbers, 2016–2025

Between 2016 and 2025 CareDx, Inc. reported revenue of $41.0M rising to $380.0M, a change of +826.8% across 10 years. Compounded, revenue has grown 14.6% a year over five years, 5.7% over three, 13.8% over the last twelve months. Net profit rose to $-21.0M.

Operating margin went from -91.9% in 2016 to -6.6% in 2025, a gain of 85.3 percentage points. The most recent net margin is 24.23%. On a trailing twelve-month basis to Jun '26, revenue is $458.0M and net profit $112.0M.

Borrowings rose from $24.0M to $26.0M, cash from operations was $42.0M in the latest year, positive in 3 of the last 10.

Return on equity has averaged -18.1% over five years, and was -6.9% in the most recent year.

The share price itself has compounded at -19.7% a year over five years, 38.5% over three, 30.8% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

CareDx, Inc. (CDNA) — frequently asked questions